Editorial and Review: 36th ASMS Asilomar Conference on Mass Spectrometry: The Role of Mass Spectrometry in Neurodegenerative Disease Research.

Abstract

ADVERTISEMENT RETURN TO ISSUEEditorialNEXTEditorial and Review: 36th ASMS Asilomar Conference on Mass Spectrometry: The Role of Mass Spectrometry in Neurodegenerative Disease ResearchJoseph A. Loo*Joseph A. LooUniversity of California, Los Angeles Los Angeles, California 90095, United States*Email: [email protected]More by Joseph A. Loohttps://orcid.org/0000-0001-9989-1437Cite this: J. Am. Soc. Mass Spectrom. 2023, 34, 5, 797–798Publication Date (Web):May 3, 2023Publication History Received11 April 2023Published online3 May 2023Published inissue 3 May 2023https://doi.org/10.1021/jasms.3c00136American Chemical Society. Published 2023 by American Chemical SocietyRIGHTS & PERMISSIONSArticle Views688Altmetric-Citations-LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit PDF (2 MB) Get e-AlertscloseSUBJECTS:Central nervous system,Lipids,Mass spectrometry,Nervous system diseases,Peptides and proteins Get e-Alerts